Big Data hiring activity decreased in the pharmaceutical industry in Q2 2023

MEEFRO July 26, 2023

0 0 2 minutes read

Notably, Management Occupations jobs accounted for a 23% share of the global pharmaceutical industry’s big data-related total new job postings in Q2 2023, down 30% over the prior quarter.

Management Occupations drive big data-related hiring activity

Management Occupations, with a share of 23%, emerged as the top big data-related job roles within the pharmaceutical industry in Q2 2023, with new job postings drop by 30% quarter-on-quarter. Computer and Mathematical Occupations came in second with a share of 18% in Q2 2023, with new job postings dropping by 26% over the previous quarter.

The other prominent big data roles include Life, Physical, and Social Science Occupations with a 14% share in Q2 2023, Business and Financial Operations Occupations with a 4% share of new job postings.

Top five companies in pharmaceutical industry accounted for 35% of hiring activity

The top companies, in terms of number of new job postings tracked by GlobalData, as of Q2 2023 were Johnson & Johnson, Novartis, Pfizer, Novo Nordisk, and Merck. Together they accounted for a combined share of 35% of all big data-related new jobs in the pharmaceutical industry.

Johnson & Johnson posted 1,599 big data-related new jobs in Q2 2023, Novartis 729 jobs, Pfizer 632 jobs, Novo Nordisk 525 jobs, and Merck 523 jobs, according to GlobalData’s Job Analytics.

Hiring activity was driven by the US with a 49.56% share of total new job postings, Q2 2023

The largest share of big data-related new job postings in the pharmaceutical industry in Q2 2023 was in the US with 49.56% followed by India (12.87%) and Germany (4.13%). The share represented by the US was ten percentage points lower than the 59.73% share it accounted for in Q1 2023.

For further understanding of GlobalData’s Big Data in Pharmaceuticals – Thematic Research buy the report here.

This content was updated on 24 July 2023